Capstone Therapeutics Corp.

Quarterly Report for period ending 2019-06-30

Quarterly Report for period ending 2019-03-31

Annual Report for period ending 2018-12-31

Quarterly Report for period ending 2018-09-30

Quarterly Report for period ending 2018-06-30

Quarterly Report for period ending 2018-03-31

Annual Report for period ending 2017-12-31

Quarterly Report for period ending 2017-09-30

Annual Report for period ending 2016-12-31

Quarterly Report for period ending 2017-06-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Notice of termination of registration of a class of securities under Section 12(g)

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Exempt (Private) Offering

Form for registration of a class of securities pursuant to Section 12(g)

Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange

Form for registration of a class of securities pursuant to Section 12(g)

Form for registration of a class of securities pursuant to Section 12(g)

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Schedule filed to report going private transactions

BP Peptides, LLC: Major Shareholders

Schedule filed to report going private transactions

Schedule filed to report going private transactions

BP Peptides, LLC: Major Shareholders

SUBIN NEIL S: Major Shareholders

Alimco Financial Corp: Major Shareholders

Alimco Financial Corp: Initial statement of beneficial ownership of securities

SUBIN NEIL S: Statement of changes in beneficial ownership of securities

BP Peptides, LLC: Major Shareholders

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

Post-effective amendment to a S-8 registration statement

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Definitive proxy statements

Preliminary revised proxy soliciting materials

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.